Why Financial Analysts in Pharma Should Love Personalized Medicine

Financial analysts have good reason to anticipate the continued growth of personalized medicine. Not only is it affecting patients and physicians but it holds plenty of promise for the pharma industry. General Strategic Development Benefits Personalized medicine encourages more vertical collaboration throughout the industry. It is therefore in the best interest of pharma companies to […]

How Partnering Trends are Changing in Personalized Medicine [INFOGRAPHIC]

While 2015 was a record year for pharma partnerships, only a fraction of those were focused on commercialization. Competitive pressures are increasing, and pharma launches are becoming less predictable. Gain insight on partnering trends in personalized medicine and solutions for a successful partnering strategy with our new infographic. Did You Love It? Share This Infographic […]